PLEASANTON, Calif - Thoratec Laboratories Corporation has announced that it will purchase Thermo Cardiosystmes, Inc. for $572 million in newly issued stock. Under the new deal, which is expected to close next year, Thoratec will exchange .835 a newly issued share for each share of Thermo Cardiosystems. Both companies are manufacturers of artificial heart devices. For more information visit www.thoratec.com.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.